In this review, we present an overview of how mucins are connected to the pathogenicity of the virus and highlight the importance of studying the glycome and mucin signature in predicting the susceptibility, progression, and response to therapy in COVID‐19 patients. This evidence concerns the gene MUC5AC and COVID-19.